More articles about Molecular Diagnostics

The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance.

OpGen, which is acquiring Curetis, said that combined revenue for both companies would have been about $6 million in 2019 had the deal been completed last year.

The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.

The agreement will bring Exalenz's BreathID Breath Test Systems, a urea breath test platform for H. pylori detection, into Meridian's portfolio.

The companies will join their respective technologies to provide pharmacogenomic information for patients undergoing genetic testing.

CareDx first sued Natera in April 2019, accusing the company of trying to mislead patients and clinicians about the superiority of its Prospera transplant test.

The Shenzhen Mammoth Public Welfare Foundation, which BGI sponsors, has also raised funding to purchase PCR and automate sample preparation instruments.

The proposed Medicines and Medical Devices Bill updates the framework for regulating IVDs following the UK's exit from the EU.